RESEARCH-USE BIOSIMILAR ANTIBODY
Prasinezumab
Monoclonal antibody · IgG1
Prasinezumab (PRX 002) is a humanized IgG1 monoclonal antibody directed against aggregated α-synuclein. Prasinezumab has the potential for Parkinson's disease research.
TARGETSNCA
YMonoclonal antibody
CATALOGSC-BS-254
CATALOG NUMBERSC-BS-254
MOLECULAR WEIGHTApprox. 145.26 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Prasinezumab (PRX 002) is a humanized IgG1 monoclonal antibody directed against aggregated α-synuclein. Prasinezumab has the potential for Parkinson's disease research.
Prasinezumab is a recombinant research-use antibody directed against SNCA.